Abstract
The aim of this communication is to increase awareness to specific problems of certain population sectors whose immunological system may be more sensitive to toxic damage than the normally functioning system. Indeed, the title of the presentation was selected with three considerations in mind: (a) It is possible and instructive to compare therapeutic immunomodulation, with which there is relatively more experience, and immunotoxicity, and by doing so to gain better insight into the general rules and potential mechanisms of toxic effects on the immune system. Moreover, therapeutic immunomodulatory agents are known to cause immunotoxicity under certain circumstances (Shoham, 1984a) and, in principle, the reversed situation is also possible. (b) Conditions of “deficiency”,“in sufficiency” or “failure” of the immune system may amplify or modify the effect of either type of agents. Accordingly, these conditions call for more caution and specific attention to potential adverse effects of such agents, which could cause further deterioration of the deficient immune system. Moreover, conditions of immunodeficiency are important targets for the therapeutic use of immunomodulating agents and these conditions may give rise to toxicity rather than benefit as as an outcome of this therapeutic manipulation. (c) There are certain similarities between the effect of age (either too young or too old) and malnutrition on the immune system, which justify considering them together in connection with potential toxic damage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alleyne, G.A.O. (1966). Cardiac function in severely malnourished Jamaican children. Clin. Sci. 30. 553–562.
Bach, J.F. (1982). Immunopotentiation. In Clinical Aspects of Immunology,, (eds. Lachmann, P.J. and Peters, D.K. ) pp. 565–578. Blackwell Scientific Public., Oxford.
Beach, R.S., Gershwin, M.E. & Hurley, L.S. (1982). Gestational zinc deprivation in mice. Persistence of immunodeficiency for three generations. Science 218 469–471.
Bender, A.D. (1964). Pharmacologic aspects of aging. A survey of the effect of increasing age on drug activity in adults. J. Am. Geriatr. Soc., 12: 114–139.
Boss, G.R., Thompson, R.F., Speigelberg, H.L., Pichler, W.J. & Seegmiller, E. (1980). Age dependency of lymphocyte ecto-5’-nucleotidase activity. J. Immunol., 125: 679–682.
Buchanan, N., Hansen, J.D.L., Van Der Walt, L.A., Robinson, R. & Koornhof, H.J. (1976). Chloramphenicol metabolism in children with PCM, Am. J. Clin. Nutr., 29: 327–328.
Campbell, T.C. (1977). Nutrition and drug metabolising enzymes. Clin. Pharmacol. Ther., 22: 699–706.
Cantor, H. & Gershon, R.K. (1980). T-cell sets: the role of their genetic programme in immunoregulation. In The Immune System: Functions and Therapy of Dysfunction (eds. Doria, G. & Eshkol, A.) pp. 13–26. Academic Press, London.
Chandra, R.K. (1974). Rosette forming T-lymphocytes and cell mediated immunity in malnutrition. Br. Med. J. f. 3: 608–609.
Chandra, R.K. (1979a). T and B lymphocyte subpopulations and leukocyte terminal deoxynucleotidyl transferase in malnutritiion. Acta Paediat. Scan., 68: 841–845.
Chandra, R.K. (1979b). Serum thymic activity in protein energy malnutrition. Clin. Exp. Immunol., 38: 228–230.
Chandra, R.K. (1980). Cell mediated immunity in nutritional imbalance. Fed. Proc, 39: 3088–3092.
Cohen, S. & Hansen, J.D.L. (1962). Metabolism of albumin and -globulin in kwashiorkor. Clin. Sei., 23: 351–359.
Cooper, M.O., Burrows, P.D. &Lawton, A.R. (1980). Generation of B cell diversity. In The Immune System: Functions and Therapy of Dysfunction (eds. Doria, G. & Eshkol, A.) pp. 1–12. Academic Press, London.
Dean, J. H., Luster, M.I. & Boorman, G.A. (1982). Immunotoxicology. In Immunopharmacology (eds. Sirois, P. and Rola-Pleszczynski, M.J pp. 349–397. Elsevier Biomedical Press, North Holland.
Decker, J.M. & Sercarz, E.E. (1974). Early simultaneous appearance of antigen binding cells in fetal sheep. Nature 252: 416–418.
Dixon, F.J. & Weigle, W.O. (1957). The nature of the immunologic inadequacy of neonatal rabbits by cell transfer studies. J. Exp.Med., 105: 75–83.
Dixon, F.J. & Weigle, W.O. (1959). The nature of the immunologic inadequacy of neonatal rabbits. II. Antibody formation by neonatal spleen cells transferred to adult recipients. J. Exp. Med., 110: 139–146.
Faith, R.E., Luster, M.I. & Moore, J.A. (1978). Chemical separation of helper cell function and delayed hypersensitivity responses. Cell. Immunol., 40: 275–284.
Finney, D.G. (1952). Statistical Methods in Biological Assays, pp. 661. Charles Griffin Ltd., London.
Friis-Hansen, B. (1961). Body water compartments in children: changes during growth and related changes in body composition. Pediatrics 28: 169–181.
Gainer, J.H. (1972). Effects of arsenials on interferon foemation Band action. Am. J. Vet. res., 33: 2583
Geokas, M.C. & Haverback, B. J. (1969). The aging gastro-intestinal tract. Am. J. Surg., 117: 881–892.
Hadden, J.W., Delmonte, L. & Oettgen, H.F. (1977). Mechanisms of immmunopotentiation. In Immunopharmacology(eds. Hadden, J.W. Coffey, R.G. and Spreafico, F.) pp. 279–314. Plenum Publishing Corp., New York.
J.M., Kampmann , J. & Laursen, H. (1970) Renal excretion of drugs in the elderly. Lancet i: 1170.
Hefton, J.M., Darlington, G.J., Gasazza, B.A. & Weksler, M.E. (1980). Immunologic studies of aging. V. Impaired proliferation of PHA responsive human lymphocytes in culture. J. Immunol., 125: 1007–1010.
Howe, M.L. & Manziello, B. (1972). Ontogenesis of the in vitroresponse of murine lymphoid cells to cellular antigens and phytomitogens. J. Immunol., 109: 534–539.
Jusko, W. J. (1973). Pharmacokinetic principles in pediatric pharmacology. Pediatric clinics N. Am., 19: 81–100.
Katom R., Takanaka, A. & Onoda, K.I. (1970). Studies on age differences in mice for the activity of drug metabolising enzymes of liver microsomes.Japan J. Pharmacol., 20; 572–576.
Kendall, M.D. (1981). Age and seasonal changes in the thymus. In The Thymus Gland (ed. Kendal, M.D. ) pp. 21–36. Academic Press, London.
Kennes, B., Hubert, C. & Neve, P. (1981). Early biochemical events associated with lymphocyte activation in aging. I. Evidence that Ca2+ dependent processes induced by PHA are impaired. Immunology 42: 119–126.
Klein, A.S. & Shoham, J. (1981). The effect of the thymic extract TP-1 (thymostimulin) on the survival rate of tumor bearing mice. Cancer Res., 41: 3217–3221.
B-cell repertoire specific for 2,4-deinitrophenyl and 2,4,6-trinitrophenyl determinants in neonatal Balb/c mice. J.Exp.Med., 141: 1133:1146.
Koller, L.D. (1980). Immunotoxicology of heavy metals. Int. J. Immunopharmac., 2: 269–279.
Koller, L.D., Exon, J.H. & Roan, J.G. (1976). Humoral antibody response in mice after single dose exposure to lead or cadmium. Proc. Soc. Exp. Biol. Med., 151: 339–342.
Krishnaswamy, K. (1978). Drug metabolism and pharmacokinetics in malnutrition. Clin. Pharmacokinetics, 3: 216–229.
Kurz, H., Michels, H. & Stickel, H.H. (1977). Differences in the binding of drugs to plasma proteins from newborn and adult man. Eur. J. Clin. Pharmacol. 11: 469–478.
Leonard, P.J. & McWilliam, K.M. (1965). The binding of aldosterone in the serum of kwashiorkor. Am. J. Clin. Nutr., 16: 360–363.
Levy, G., Khanna, N.N., Soda, D.M., Tsuzuki, 0. & Stern, L. (1975). Pharmacokinetics of acetaminophen in the human neonate. Pediatrics 55: 818–825.
Makinodan, T. & Yunis, E. (1977). Immunology and Aging. Plenum Publishing Corp., New York.
McLean, A.E.M. (1971). Conversion by the liver of inactive molecules into toxic molecules. In Mechanism of Toxicity (ed. Aldridge, W.N. ) pp. 219–228. MacMillan, London.
Moody, C.E. Innes, J.B., Staiano-Coico, Incefy, G.S. Thaler, H.T. & Weksler, M.E. (1981). Lymphocyte transformation Induced by autologous cells. XI. The effect of age on the autologous mixed lymphocyte reaction. Immunology 44: 431–438.
Morselli, P.L. (1976). Clinical pharmacokinetics in neonates. Clinical Pharmacokinetics 1: 81–95.
Newmann, C.G., Lawler, G.J., Stiehm, E.R., Swendseid, M.E. Newton, C., Herbert, J., Ammann, A.J.& Jacob, M. (1975) Immunologic responses in malnourished children. Am. J. Clin. Nutr., 28: 89–104.
Niederhuber, J.E., Allen, P. & Mayo, L. (1979). The expression of la antigenic determinants on macrophages required for the in vitroantibody. J. Immunol., 122; 1342–1349.
Pitlick, W., Painter, M. & Pippenger, C. (1978). Phénobarbital pharmacokinetics in neonates. Clin. Pharmacol. Therap., 23: 346–350.
Playfair, J.H.L. (1978). Strain differences in the immune response of mice. I.The neonatal response to sheep red blood cells. Immunology 15: 35–50.
Prasad, A.S. (1983). Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nutrition Rev., 41: 197–208.
Press, J.L. & Klinman, N.R. (1973). Enumeration and analysis of antibody forming precursors in the neonatal mouse. J. Immunol., 111: 829–835.
Ptak, W., Naidorf, K.F., Strzyzewska, J. & Gershon, R.K. (1979). Ontogeny of cells involved in the suppressor circuit of the immune response. Eur. J. Immunol., 9: 495–500.
Radl, J., Deglopper, E., Vandenberg, P. & Janzwieten, M.J. (1980). Idiopathic paraproteinemia. III. Increased frequency of rare proteinemia in thymectomized aging C57Bl/KalwRij and CBA/BrARij mice. J. Immunol., 125: 31–35.
Rane, A. & Sjoqvist, F. (1972). Drug metabolism in the human fetus and newborn infant. Pediatr. Clin. N. Am., 19: 37–50.
Rees, A.J. & Lockwood, C.M. (1982). Immunosuppressive drugs in clinical practice. In Clinical Aspects of Immunology (eds. Lachmann, P.J. and Peters, D.K.) pp. 5o7–564. Blackwell Scientific Public-, Oxford.
Rowe, J.W., Andres, R. & Tobin, J.D. (1976). The effect of age on creatinine clearance in man: a cross-sectional and longitudinal study. J. Gerontol., 31: 155–163.
Shoham, J. (1984a). Specific safety problems of in appropriate immune responses to immunostimulating agents. Trends Pharmacol. Sci. (in press).
Shoham, J. (1984b). Clinical Assessement of the safety of immunostimulating drugs-past experience and guidelines for the future. In Present Problems and future trtends in drugs Toxicology (Ed. Zbinden, G. )(in press).
Shoham, J. & Eshel, I. (1980). Thymic hormonal effect on human peripheral blood lymphocytes. III. Conditions for mixed lymphocyte tumor culture assay. J. Immunol. Methods 37: 261–273.
Shoham, J., Cohen, M., Chandali, Y. & Avni, A. (1980). Thymic hormonal effect on human peripheral blood lymphocytes. I. Reciprocal effect on T and B lymphocytes. Immunology 41: 353–359.
Smythe, P.M., Schonland, M., Brereton-Stiles, G.C. (1971). Thymolymphatic deficiency and depression of cell mediated immunity in protein-caloric malnutrition. Lancet 2: 939–940.
Spear, P.G., Wang, A.-L., Rutishauser, U. & Edelman, G.M. (1973). Characterization of splenic lymphoid cells in fetal and newborn mice. J. Exp. Med., 138: 557–573.
Spreafico, F. & Anaclerio, A. (1977). Immunosuppressive agents. In Immunopharmacology (eds. Hadden, J.W., Coffey, R.G. and Spreafico, F. ) pp. 245–278. Plenum Publishing Corp., New York.
Spreafico, F. & Vecchi, A. (1984). Immunomodulation by xenobiotics: The open field of immunotoxicology. In Immunomodulation: New Frontiers and Advances. (eds. Fudenberg, H.H., Whitten, H.D. and Ambrogi, F. ) pp. 311–330. Plenum Publishing Corp., New York.
Spreafico, F., Vecchi, A., Conti, G. & Sironi, M. (1981). On the heterogeneity of immunotherapeutic agents. In Advances in Immunopharmacology fed. Hadden, J.W.J pp. 51–63. Pergamon Press, Oxford.
Thoman, M.L. & Weigle, W.0. (1982). Cell mediated immunity in aged mice: an underlying lesion in IL2 synthesis. J. Immunol., 128: 2358–2361.
Toyama, I. & Kolmer, J.A. (1918). The influence of arsphe- namine and mercuric chloride on complement and antibody production. J. Immunol., 3: 301–312.
Vestal, R.E. (1978). Drug use in the elderly: A review of problems and special considerations. Pract. Ther., 16: 358–382.
Vink, C.L.J. (1959). Liver function and age. Clin. Chim.Actas 4: 674–682.
Vos, J.G. (1979). Immune suppression as related to toxicology. CRC Crit. Rev. Toxicol., 5: 67–101.
Walford, R.L. & Bergmann, K. (1979). Influence of genes associated with the main histocompatibility complex on deoxyribonucleic acid excision repair capacity and bleomycin sensitivity in mouse lymphocytes.Tissue Antigens 14: 336–342.
Wallace,, S., Whiting, B. & Runcie, J. (1976). Factors affecting drug binding in plasma of elderly patient.Br. J. Clin. Pharmacol: 327–330.
Watts, T. (1969). Thymus weights in malnourished children. J. Trop.Pediatr., 15: 155–158. Who Report (1978). “Principles and Methods for Evaluating the Toxicity of Chemicals, Part I”. Environmental Health Criteria 6. p.116. World Health Organization, Geneva.
Woodruff, J.F. (1970). The influence of quantitated post-weaning undernutrition of adult mice. II. Alteration oh host defense mechanismsJ. Infec. Dis., 121: 164 101.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 ECSC, EEC, EAEC, Brussels-Luxembourg and WHO, Geneva
About this chapter
Cite this chapter
Shoham, J. (1987). Vulnerability to Toxic or Therapeutic Immunomodulation — As Two Complementary Aspects of Age and Nutrition Dependent Immunodeficiency. In: Berlin, A., Dean, J., Draper, M.H., Smith, E.M.B., Spreafico, F. (eds) Immunotoxicology. Developments in Hematology and Immunology, vol 16. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4307-0_28
Download citation
DOI: https://doi.org/10.1007/978-94-009-4307-0_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8414-7
Online ISBN: 978-94-009-4307-0
eBook Packages: Springer Book Archive